Related Experiment Video
Updated: Jul 15, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Mitral regurgitation outcomes after transcatheter atrial septal defect closure
Michiyo Yamano1, Tetsuhiro Yamano1, Takeshi Nakamura1
1Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Background:
Worsening mitral regurgitation (MR) is a complication of intervention for atrial septal defect (ASD). Little is known about mitral valve (MV) characteristics associated with worsening MR. We aimed to elucidate MR outcomes and predictors of worsening MR after transcatheter ASD closure.
Methods:
We analyzed changes in MR from prior to transcatheter ASD closure to 6 months after the procedure and predictors of worsening MR via baseline transthoracic echocardiography in 238 patients (64.7% females; mean age, 53 ± 22 years).
Results:
Worsening MR was defined as worsening to moderate in patients with less than or equal to mild MR at baseline or vena contracta width increasing of ≥2 mm by 6-month follow-up in patients with moderate MR. Worsening MR was observed in 29 patients (12.2%). The associated echocardiographic findings were pseudoprolapse, hamstringing, stiffness, and anteroposterior and intercommissural mitral annulus diameter in the univariable logistic regression analysis (all P < 0.05). Multivariable analysis after adjusting for age; long-standing persistent atrial fibrillation; and ASD size showed that models combining MV leaflet findings such as pseudoprolapse or hamstringing, or anterior leaflet stiffness with the ratio of the sum of anterior and posterior leaflet lengths to intercommissural mitral annulus diameter were statistically significant for predicting worsening MR (R2 = 0.393, P < 0.001 and R2 = 0.385, P < 0.001, respectively).
Conclusions:
Worsening MR after transcatheter ASD closure might depend on MV leaflet findings and annulus size in patients with long-standing persistent atrial fibrillation.
Insights
Mitral regurgitation (MR) can worsen after atrial septal defect (ASD) closure. Echocardiography can predict worsening MR by assessing mitral valve leaflet characteristics and annulus size, especially in patients with atrial fibrillation.
Area of Science:
- Cardiology
- Medical Imaging
- Interventional Cardiology
Background:
- Worsening mitral regurgitation (MR) is a known complication following intervention for atrial septal defect (ASD).
- Limited understanding exists regarding mitral valve (MV) characteristics that predict this worsening MR.
- This study investigates MR outcomes and predictors after transcatheter ASD closure.
Purpose of the Study:
- To identify echocardiographic predictors of worsening mitral regurgitation (MR) after transcatheter atrial septal defect (ASD) closure.
- To elucidate the relationship between baseline MV characteristics and the development or progression of MR post-procedure.
- To improve patient selection and management strategies for transcatheter ASD closure.
Main Methods:
- Analysis of MR changes from baseline to 6-month follow-up in 238 patients undergoing transcatheter ASD closure.
- Baseline transthoracic echocardiography was used to assess MV characteristics and predict worsening MR.
- Worsening MR was defined by specific criteria including increase in moderate MR or vena contracta width.
Main Results:
- Worsening MR was observed in 12.2% of patients within 6 months post-procedure.
- Univariable analysis identified pseudoprolapse, hamstringing, stiffness, and mitral annulus dimensions as associated findings.
- Multivariable models combining leaflet findings (pseudoprolapse, hamstringing, anterior leaflet stiffness) with annular dimensions significantly predicted worsening MR (R²=0.393 and R²=0.385).
Conclusions:
- Mitral regurgitation worsening after transcatheter ASD closure is associated with specific mitral valve leaflet findings and annulus size.
- These echocardiographic parameters are valuable for predicting MR progression, particularly in patients with long-standing persistent atrial fibrillation.
- Further research may refine these predictors for improved clinical decision-making.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation IV: Nursing Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

